Literature DB >> 30396257

Understanding of Neurological Diseases.

Chang-Ju Kim1.   

Abstract

Entities:  

Year:  2018        PMID: 30396257      PMCID: PMC6234726          DOI: 10.5213/inj.1820edi.007

Source DB:  PubMed          Journal:  Int Neurourol J        ISSN: 2093-4777            Impact factor:   2.835


× No keyword cloud information.
This issue of the International Neurourology Journal presented a special issue on the causes and treatments of neurological diseases considered as incurable diseases in modern medicine and science. It would be better if more articles could be included in the issue, however, the updated underlying mechanisms and suggestable treatments of major neurological diseases were supplied. Hussaini and Jang [1] reviewed the role of astrocyte, which has recently gained attention, in the onset of neurological diseases, while Lee et al. [2] presented and discussed presynaptic dysfunction as a cause of Parkinson disease. In addition, BubR1 insufficiency was suggested as the cause of affective behavior and memory impairments [3]. Treatment modalities for neurological diseases include stem cells, drugs, or alternative and complementary treatments such as exercise. Lim et al. [4] used human turbinate-derived mesenchymal stem cells for the brain stroke. Among the diverse actions of dexmedetomidine, the possibility of treatment for depression by sleep deprivation was studied [5]. The effect of treadmill running on Purkinje cell loss in Parkinson disease [6] and the mechanism of treadmill exercise to overcome short-term memory impairments in cerebral palsy were also suggested [7]. As can be seen in the poster topic “Knowing Brain Healing Brain,” of an academic society, many studies are being done to overcome brain diseases. Management of neurological diseases is important because it affects the quality of life and survival of patients, furthermore, neurological diseases also cause secondary peripheral diseases including urological diseases. For this reason, the International Neurourology Journal published a special issue for neurological diseases to achieve a fundamental approach for urologic diseases. I would like to thank the authors for contributing valuable articles and hope that this chance will provide a new perspective in the urology field.
  7 in total

1.  Therapeutic Potential of Human Turbinate-Derived Mesenchymal Stem Cells in Experimental Acute Ischemic Stroke.

Authors:  Hyosun Lim; Sun Hwa Park; Sung Won Kim; Kyung-Ok Cho
Journal:  Int Neurourol J       Date:  2018-10-31       Impact factor: 2.835

2.  Treadmill Exercise Improves Motor Function by Suppressing Purkinje Cell Loss in Parkinson Disease Rats.

Authors:  Jae-Min Lee; Tae-Woon Kim; Sang-Seo Park; Jin-Hee Han; Mal-Soon Shin; Baek-Vin Lim; Sang-Hoon Kim; Seung-Soo Baek; Young Sam Cho; Khae Hawn Kim
Journal:  Int Neurourol J       Date:  2018-10-31       Impact factor: 2.835

3.  BubR1 Insufficiency Impairs Affective Behavior and Memory Function in Mice.

Authors:  Chang Hoon Cho; Zhongxi Yang; Ki Hyun Yoo; Alfredo Oliveros; Mi Hyeon Jang
Journal:  Int Neurourol J       Date:  2018-10-31       Impact factor: 2.835

4.  Presynaptic Dysfunction by Familial Factors in Parkinson Disease.

Authors:  Wongyoung Lee; Soulmee Koh; Soondo Hwang; Sung Hyun Kim
Journal:  Int Neurourol J       Date:  2018-10-31       Impact factor: 2.835

5.  Dexmedetomidine Ameliorates Sleep Deprivation-Induced Depressive Behaviors in Mice.

Authors:  Eun-Jin Moon; Il-Gyu Ko; Sung-Eun Kim; Jun-Jang Jin; Lakkyong Hwang; Chang-Ju Kim; Hyeonjun An; Bong-Jae Lee; Jae-Woo Yi
Journal:  Int Neurourol J       Date:  2018-10-31       Impact factor: 2.835

6.  New Roles for Old Glue: Astrocyte Function in Synaptic Plasticity and Neurological Disorders.

Authors:  Syed M Q Hussaini; Mi Hyeon Jang
Journal:  Int Neurourol J       Date:  2018-10-31       Impact factor: 2.835

7.  PI3K-Akt-Wnt Pathway Is Implicated in Exercise-Induced Improvement of Short-term Memory in Cerebral Palsy Rats.

Authors:  Jung-Wan Cho; Sun-Young Jung; Dae-Young Kim; Yong-Rak Chung; Hyun-Hee Choi; Jung-Won Jeon; Jin-Hee Han
Journal:  Int Neurourol J       Date:  2018-10-31       Impact factor: 2.835

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.